Keyword: Pristiq

2016 was a mixed year for Lupin. It completed the acquisition of U.S.-based Gavis in March 2016, obtaining its first manufacturing site in the U.S., along with some 60 ANDA filings pending approval with the FDA at that time. But a Form 483 for its Goa plant and two large-scale drug recalls because of failed ingredients were setbacks.

Pfizer's antidepressant Pristiq hit the market in 2008, just as its predecessor, Effexor, was nearing the end of its branded life. As a "new-and-improved" version of Effexor's active ingredient, venlafaxine, Pristiq was the hoped-for successor to that blockbuster brand, but it never cracked $1 billion in the U.S.